E-LIB Suche - Ergebnisse für: Kachroo, Sumesh

1

Real-World Maintenance Phase Persistence on Ustekinumab and..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Shah, Aditi...
Patient Preference and Adherence. 18 (2024) - p. 809-820 , 2024

2

REAL-WORLD TREATMENT PERSISTENCE AMONG ADVANCED THERAPY-EXP..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Boonmak, Porpong...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S38-S38 , 2024

Link: https://doi.org/10.1093/..

3

PATIENT PERCEPTIONS OF ENDOSCOPIC TESTING IN THE MANAGEMENT..:

Duncan, Eric ; Sanon, Myrlene ; Griffo, Cindy...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S84-S84 , 2024

Link: https://doi.org/10.1093/..

4

REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH UL..:

Burbage, Sabree ; Harvey, Niamh ; Godwin, Bridget...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S86-S87 , 2024

Link: https://doi.org/10.1093/..

5

REAL-WORLD LONG-TERM TREATMENT PERSISTENCE AMONG BIO-NAÏVE ..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Boonmak, Porpong...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S37-S38 , 2024

Link: https://doi.org/10.1093/..

6

The economic impact of suboptimal treatment and treatment s..:

Gagnon-Sanschagrin, Patrick ; Sanon, Myrlene ; Davidson, Mikhaïl...
Journal of Medical Economics. 27 (2024) 1 - p. 931-940 , 2024

Link: https://doi.org/10.1080/..

7

PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG ADVANCE..:

Kachroo, Sumesh ; Zhdanava, Maryia ; Burbage, Sabree...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S36-S37 , 2024

Link: https://doi.org/10.1093/..

8

Tu1822 COMPARISON OF REAL-WORLD HEALTHCARE RESOURCE UTILIZA..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Boonmak, Porpong...
Gastroenterology. 166 (2024) 5 - p. S-1422-S-1423 , 2024

Link: https://doi.org/10.1016/..

9

PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG ADVANCE..:

Boonmak, Porpong ; Kachroo, Sumesh ; Zhdanava, Maryia...
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S00-S00 , 2024

Link: https://doi.org/10.1093/..

10

ASSOCIATION OF CYCLING BETWEEN ANTI-TNFS VERSUS SWITCHING T..:

Zhdanava, Maryia ; Ding, Zhijie ; Manceur, Ameur...
Inflammatory Bowel Diseases. 29 (2023) Supplement_1 - p. S34-S34 , 2023

Link: https://doi.org/10.1093/..

11

Persistence Among Patients with Crohn Disease Previously Tr..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Manceur, Ameur M....
Clinical Therapeutics. 45 (2023) 8 - p. 770-777 , 2023

Link: https://doi.org/10.1016/..

12

SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMON..:

Zhdanava, Maryia ; Ding, Zhijie ; Manceur, Ameur...
Inflammatory Bowel Diseases. 29 (2023) Supplement_1 - p. S37-S37 , 2023

Link: https://doi.org/10.1093/..

13

Su1137 SUBOPTIMAL TREATMENT IN PATIENTS WITH CROHN'S DISEAS..:

Gagnon-Sanschagrin, Patrick ; Sanon, Myrlene ; Davidson, Mikhail...
Gastroenterology. 164 (2023) 6 - p. S-541-S-542 , 2023

Link: https://doi.org/10.1016/..

14

ASSOCIATION OF CYCLING BETWEEN ANTI-TNFS VERSUS SWITCHING T..:

Zhdanava, Maryia ; Ding, Zhijie ; Manceur, Ameur...
Gastroenterology. 164 (2023) 4 - p. S42-S43 , 2023

Link: https://doi.org/10.1053/..

15

REAL-WORLD USTEKINUMAB PERSISTENCE IN PATIENTS WITH ULCERAT..:

Zhdanava, Maryia ; Kachroo, Sumesh ; Shah, Aditi...
Inflammatory Bowel Diseases. 29 (2023) Supplement_1 - p. S36-S37 , 2023

Link: https://doi.org/10.1093/..